Lung factor

Marjukka Myllärniemi (professor) is the principal investigator of Lung factor research group. She is a professor of Pulmonary Medicine and Allergology at the University of Helsinki and works as the pulmonary physician-in-charge of the hospital ward 6B at the Heart and Lung Center, Helsinki University Hospital. The research of Lung factor focuses on Idiopathic pulmonary fibrosis, but more recently, rare pulmonary malignancies have been incorporated into the scope.

Eva Sutinen (B.Sc) is the research coordinator of the group.  She helps investigators with practical things like purchases, the recruit of patients to research and the update of information to the patient registers.

Hely Ollila (BHSc) is a biomedical laboratory scienist and works as a research research nurse in Lung factor. Hely collects consents from patients, helps investigators and updates information to the patient registers.

Ilkka Ilonen (MChD) is a surgeon specialized in general thorax and esophageal surgery and he is specificly interested in lung cancer, mesothelioma and esophageal diseases. Ilkka finished his doctoral dissertation in 2011 in the University of Helsinki on non-small cell lung cancer. Ilkka worked in the years 2015-2017 as a member of EACTS Council and thoracic domain. During the years of 2017 and 2018, he will accomplish a period of advanced thoracic surgical Oncology-Fellowship at the Memorial Sloan Kettering Cancer Center hospital.

Jaana Kaunisto (M.D.) is a PhD student. Jaana is a doctor specializing in pulmonary diseases and allergology. Jaana lives in Turku and works at Tyks Turku University Hospital in the pulmonary clinic. Jaana has been involved in building the Finnish IPF register since its inception. She takes care of the register of southwest Finland. Jaana is doing a doctoral dissertation on the prevalence and prediction of idiopathic pulmonary fibrosis in Finland based on IPF inventory data.

Eeva Kuosma (MSSc) works as a statistical expert in the research group and helps its members with all the questions and problems on statistical analysis. She selects statistical methods suitable for the research set up, conducts the analysis with statistical software, and construes the results of analyzes. Eeva participates in the writing of the article involving (specifically) statistical methods and results.

Sanna Laaksonen (M.D.) graduated from Helsinki University’s Medical faculty in January 2016 and continued afterwards with the service at a health center in the city of Helsinki. Now she’s working as a specializing physician at the Institute of Pathology in HUSLAB, where she is currently doing research on maglinant pleural mesothelioma.

Kati Mäkelä (B.M.) is one of Lung factor’s investigators doing the doctoral dissertation. Already in the beginning of medical studies, Kati was interested in lung diseases. At the start of clinical studies, Marjukka had a lecture on lung diseases, which impressed Kati. Thus she started to do advanced studies under the direction of Marjukka, which expanded to dissertation research. Kati is investigating possible histopathological risks related to the course of Idiopathic pulmonary fibrosis. Kati is especially interested in finding out whether there is a relationship between idiopathic pulmonary fibrosis and inorganic particles detectable by a light microscope.

Juuso Paajanen (M.D.) is a doctor specializing in pulmonary diseases and allergology. Juuso is working on the research of mesothelioma, which considers the incidence of malignant pleural mesothelioma, its treatment practices, radiological changes in Finland and new potential biomarkers.

Ida Pesonen (M.D.) is spezializing in pulmonary medicine and allergology at Karolinska Universitetssjukhuset in Stockholm, while doing her doctoral dissertation at Karolinska Institute. In the research group she has been working on the pulmonary fibrosis register. In Sweden they have set up a similar register in September 2014. Therefore in a part of her dissertation she will compare Finnish and Swedish IPF-patients.

Kaisa Rajala (M.D.) is a specialist in Geriatrics and General Practice. In addition she has a special competence in Palliative medicine. She works as a Palliative consultant in Helsinki University Hospital and in Terho Hospice. Her research in Lung factor is on Idiopathic pulmonary fibrosis (IPF) and it focuses mainly on IPF patients’ quality of life and symptoms. She meets IPF-patients also in her work in the clinical practice of palliative care.

Ville Vartiainen (B.M., M.Sc.) is a doctoral student at Lung factor. Ville’s dissertation focuses on the development of inhaled anti-fibrotics. The project is a multidisciplinary research project in cooperation with researchers from the Aalto University’s Department of Applied Physics.




Now at Lung factor / News

Ethical board approval for the FikSu -study

The ethical board at the Helsinki University Central Hospital has […]

BMC Pulm Med classifies our work as highly accessed

Our systematic review on IPF epidemiology has been ranked as […]

Finnish update on IPF in Duodecim

In the latest issue of Duodecim,  Finnish researchers publish an […]

Follow us on Facebook

Are you interested in our research? Please like us on […]

Archive »